Home Cart Sign in  
Chemical Structure| 1150271-61-6 Chemical Structure| 1150271-61-6

Structure of 1150271-61-6

Chemical Structure| 1150271-61-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 1150271-61-6 ]

CAS No. :1150271-61-6
Formula : C15H18BF3O4
M.W : 330.11
SMILES Code : O=C(OC)C1=CC(C(F)(F)F)=CC(B2OC(C)(C)C(C)(C)O2)=C1
MDL No. :MFCD12026075
InChI Key :UDZGGUNDDHBCGY-UHFFFAOYSA-N
Pubchem ID :46739343

Safety of [ 1150271-61-6 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 1150271-61-6 ] Show Less

Physicochemical Properties

Num. heavy atoms 23
Num. arom. heavy atoms 6
Fraction Csp3 0.53
Num. rotatable bonds 4
Num. H-bond acceptors 7.0
Num. H-bond donors 0.0
Molar Refractivity 79.2
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

44.76 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.0
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

3.65
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

3.94
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.43
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

2.87
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.58

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-4.12
Solubility 0.0253 mg/ml ; 0.0000767 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-4.28
Solubility 0.0174 mg/ml ; 0.0000526 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-4.93
Solubility 0.00385 mg/ml ; 0.0000117 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

Yes
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.72 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

3.25

Application In Synthesis of [ 1150271-61-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1150271-61-6 ]

[ 1150271-61-6 ] Synthesis Path-Downstream   1~8

  • 1
  • 3-bromo-5-trifluoromethylbenzoic acid methyl ester [ No CAS ]
  • [ 73183-34-3 ]
  • [ 1150271-61-6 ]
YieldReaction ConditionsOperation in experiment
72% With potassium acetate;(1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; In N,N-dimethyl-formamide; at 90.0℃; for 2.0h;Inert atmosphere; Step 2: Methyl 3-(4.4.5.5-tetramethyl-1.3,2-dioxaborolan-2-ylV5-(trifluoromethyl)benzoate (P42)A solution of compound P42a (2.51 g, 8.90 mmol), B2Pin2 (2.71 g, 10.7 mmol), AcOK (1.75 g, 17.8 mmol) and Pd(dppf)CI2 (300 mg) in dry DMF (40 mL) was heated at 90C for 2 h under N2. The mixture was quenched with water and extracted with EA. The combined organic layers were washed with water and brine consecutively, dried over Na2S04, filtered, concentrated and purified by CC (PE/EA = 50/1) to give compound P42 (2.11 g, 72%) as a white solid.
  • 2
  • [ 328-67-6 ]
  • [ 1150271-61-6 ]
  • 3
  • [ 1150271-61-6 ]
  • [ 1442432-65-6 ]
  • [ 1442425-35-5 ]
YieldReaction ConditionsOperation in experiment
63% With bis-triphenylphosphine-palladium(II) chloride; tetrabutylammomium bromide; potassium carbonate; In 1,4-dioxane; water; at 100.0℃; for 1.5h;Inert atmosphere; Microwave irradiation; Step 1 : Methyl 3-(1-(cvclohexylmethyl)-5-methyl-4-(oxetan-3-ylcarbarnoyl)-1 --pyrrol-2-vn-5- (trifluoromethyl)benzoate (13) A mixture of 5-bromo-1-(cyclohexylmethyl)-2-methyl-/V-(oxetan-3-yl)-1 H-pyrrole-3- carboxamide (1.54 g, 4.66 mmol), compound P68 (1.50 g, 4.24 mmol), K2C03 (1.46 g, 10.6 mmol) and TBAB (60 mg, 0.18 mmol) in 1 ,4-dioxane/H2O(10 mLJ5 ml_) was added Ph(PPh3)2CI2 (300 mg) under N2. The solution was heated under microwave conditions at 100C for 1.5 h. Water was added and the solution was extracted with EA. The organic layer was washed with brine, dried over NaS04, filtered, concentrated and purified by CC (PE/EA = 5/1) to give compound 13 (1.12 g, 63%) as a colorless solid.
  • 4
  • [ 1150271-61-6 ]
  • 3,5-dimethoxyphenyl 2,3,4,5,6-pentafluorobenzenesulfonate [ No CAS ]
  • methyl 3',5’-dimethoxy-5-(trifluoromethyl)[1,1'-biphenyl]-3-carboxylate [ No CAS ]
YieldReaction ConditionsOperation in experiment
89% With bis-triphenylphosphine-palladium(II) chloride; potassium phosphate monohydrate; In tert-butyl alcohol; at 28.0℃; for 12.0h;Schlenk technique; Inert atmosphere; Sealed tube; General procedure: Procedure A: To a Schlenk tube equipped with a magnetic stiring bar and a teflon septum was charged K3PO4.H2O (1.5 mmol, 3 equiv), aryl pentafluorobenzene sulfonate (0.5 mmol, 1.0 equiv), aryl boronic acid (0.75 mmol, 1.5 equiv) and Pd(PPh3)2Cl2 (0.015 mmol, 3 mol%). The tube was then capped with a rubber septum, evacuated and backfilled with nitrogen and this cycle was repeated twice. Under an inertatmosphere, tert - butanol (3 mL) was added via syringe. Under a positive pressure of nitrogen, the rubber septum was replaced with a Teflon screw cap and this was sealed. The Schlenk tube was stirred at room temperature for the time indicated. When the reaction was completed according to TLC or GCMS (FID), thereaction mixture was diluted with EtOAc (5 mL) and filtered through celite bed. The organic layer was concentrated under reduced pressure. The residue was purified through silica gel (230 - 400 mesh) column chromatography using 1-10% ethyl acetate in petroleum ether to afford the product.
  • 5
  • [ 1150271-61-6 ]
  • C9H6F3N3O2 [ No CAS ]
  • 7
  • [ 1150271-61-6 ]
  • (nosyl)ethyl-4-((3-azidopropyl)carbamoyl)-2-iodobenzoic amide [ No CAS ]
  • C28H26F3N7O8S [ No CAS ]
  • 8
  • [ 1150271-61-6 ]
  • [(SIPr)Pd(CHF2)Cl]2 [ No CAS ]
  • methyl 3-(difluoromethyl)-5-(trifluoromethyl)benzoate [ No CAS ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 1150271-61-6 ]

Fluorinated Building Blocks

Chemical Structure| 1045795-70-7

A109708 [1045795-70-7]

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)benzoate

Similarity: 0.95

Chemical Structure| 1416721-24-8

A111294 [1416721-24-8]

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)benzaldehyde

Similarity: 0.84

Chemical Structure| 325142-82-3

A114283 [325142-82-3]

4,4,5,5-Tetramethyl-2-(3-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane

Similarity: 0.80

Chemical Structure| 69807-91-6

A130067 [69807-91-6]

2-(3,5-Bis(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.80

Chemical Structure| 214360-65-3

A143941 [214360-65-3]

4,4,5,5-Tetramethyl-2-(4-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane

Similarity: 0.79

Organoborons

Chemical Structure| 1045795-70-7

A109708 [1045795-70-7]

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)benzoate

Similarity: 0.95

Chemical Structure| 480425-35-2

A112753 [480425-35-2]

Methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate

Similarity: 0.84

Chemical Structure| 944392-68-1

A207573 [944392-68-1]

Dimethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isophthalate

Similarity: 0.84

Chemical Structure| 1416721-24-8

A111294 [1416721-24-8]

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)benzaldehyde

Similarity: 0.84

Chemical Structure| 171364-80-0

A101074 [171364-80-0]

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate

Similarity: 0.83

Aryls

Chemical Structure| 1045795-70-7

A109708 [1045795-70-7]

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)benzoate

Similarity: 0.95

Chemical Structure| 480425-35-2

A112753 [480425-35-2]

Methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate

Similarity: 0.84

Chemical Structure| 944392-68-1

A207573 [944392-68-1]

Dimethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isophthalate

Similarity: 0.84

Chemical Structure| 1416721-24-8

A111294 [1416721-24-8]

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)benzaldehyde

Similarity: 0.84

Chemical Structure| 171364-80-0

A101074 [171364-80-0]

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate

Similarity: 0.83

Esters

Chemical Structure| 1045795-70-7

A109708 [1045795-70-7]

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)benzoate

Similarity: 0.95

Chemical Structure| 480425-35-2

A112753 [480425-35-2]

Methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate

Similarity: 0.84

Chemical Structure| 944392-68-1

A207573 [944392-68-1]

Dimethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isophthalate

Similarity: 0.84

Chemical Structure| 171364-80-0

A101074 [171364-80-0]

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate

Similarity: 0.83

Chemical Structure| 903895-48-7

A309986 [903895-48-7]

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate

Similarity: 0.82

Trifluoromethyls

Chemical Structure| 1045795-70-7

A109708 [1045795-70-7]

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)benzoate

Similarity: 0.95

Chemical Structure| 1416721-24-8

A111294 [1416721-24-8]

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)benzaldehyde

Similarity: 0.84

Chemical Structure| 325142-82-3

A114283 [325142-82-3]

4,4,5,5-Tetramethyl-2-(3-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane

Similarity: 0.80

Chemical Structure| 69807-91-6

A130067 [69807-91-6]

2-(3,5-Bis(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.80

Chemical Structure| 214360-65-3

A143941 [214360-65-3]

4,4,5,5-Tetramethyl-2-(4-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane

Similarity: 0.79